How COVID-19 has reshaped the enforcement of the 21st Century Cures Act

Back in March, new rules mandating how health systems must improve their interoperability methods were published by the Department of Health and Human Services. In a new white paper, IMO’s Chief Medical Officer, Andrew S. Kanter, MD, explores how the coronavirus pandemic has changed the plans for implementation and revealed gaps in the legislation.
21st Century Cures Act - COVID-19

In 2016, the 21st Century Cures Act put the spotlight on healthcare’s need for increased interoperability. When Final Rules were passed in March, their goal was to enforce the Act’s mandates as quickly as possible. Now, COVID-19 has not only highlighted the urgent need for this data sharing, but has also taxed health systems like never before.

Even prior to the pandemic, the Rules set forth an ambitious timeline for compliance with the new regulations – a mere six months for certain elements. In early spring, some health systems were already raising concerns that this time frame was too aggressive, arguing that they placed institutions with fewer resources at a disadvantage.

In IMO’s latest white paper, we take a look at how COVID-19 has impacted the implementation of the Cures Act – from adjusting the due dates, to underscoring the critical importance of increasing and improving data sharing as quickly as possible.

To download The 21st Century Cures Act in the age of COVID-19, click on the button below.

Interested in more IMO Health resources?

Sign up today and have resources delivered straight to your inbox.

Latest Resources​

Discover how smarter problem list tooling helps providers and payers close data gaps, streamline risk adjustment, and improve reimbursement accuracy.
Learn expert-backed strategies for boosting healthcare tech adoption, engaging hesitant clinicians, and refining clinical workflows in 2025.
Meet Justin, John, and Chris, three employees who left and later returned to IMO Health, drawn to its unique culture and extraordinary...